AAAAAA

   
Results: 1-25 | 26-35
Results: 1-25/35
Residual viral replication during antiretroviral therapy boosts human immunodeficiency virus type 1-specific CD8(+) T-cell responses in subjects treated early after infection
Authors: Ortiz, GM Hu, J Goldwitz, JA Chandwani, R Larsson, M Bhardwaj, N Bonhoeffer, S Ramratnam, B Zhang, LQ Markowitz, MM Nixon, DF
Citation: Gm. Ortiz et al., Residual viral replication during antiretroviral therapy boosts human immunodeficiency virus type 1-specific CD8(+) T-cell responses in subjects treated early after infection, J VIROLOGY, 76(1), 2002, pp. 411-415
The virological and immunological consequences of structured treatment interruptions in chronic HIV-1 infection
Authors: Garcia, F Plana, M Ortiz, GM Bonhoeffer, S Soriano, A Vidal, C Cruceta, A Arnedo, M Gil, C Pantaleo, G Pumarola, T Gallart, T Nixon, DF Miro, JM Gatell, JM
Citation: F. Garcia et al., The virological and immunological consequences of structured treatment interruptions in chronic HIV-1 infection, AIDS, 15(9), 2001, pp. F29-F40
A simple and rapid magnetic bead separation technique for the isolation oftetramer-positive virus-specific CD8 T cells
Authors: McDermott, AB Spiegel, HML Irsch, J Ogg, GS Nixon, DF
Citation: Ab. Mcdermott et al., A simple and rapid magnetic bead separation technique for the isolation oftetramer-positive virus-specific CD8 T cells, AIDS, 15(6), 2001, pp. 810-812
An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants
Authors: Rose, NF Marx, PA Luckay, A Nixon, DF Moretto, WJ Donahoe, SM Montefiori, D Roberts, A Buonocore, L Rose, JK
Citation: Nf. Rose et al., An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants, CELL, 106(5), 2001, pp. 539-549
Structured antiretroviral treatment interruptions in chronically HIV-1-infected subjects
Authors: Ortiz, GM Wellons, M Brancato, J Vo, HTT Zinn, RL Clarkson, DE Van Loon, K Bonhoeffer, S Miralles, GD Montefiori, D Bartlett, JA Nixon, DF
Citation: Gm. Ortiz et al., Structured antiretroviral treatment interruptions in chronically HIV-1-infected subjects, P NAS US, 98(23), 2001, pp. 13288-13293
Inhibition of human immunodeficiency virus type 1 gp120 presentation to CD4 T cells by antibodies specific for the CD4 binding domain of gp120
Authors: Hioe, CE Tuen, M Chien, PC Jones, G Ratto-Kim, S Norris, PJ Moretto, WJ Nixon, DF Gorny, MK Zolla-Pazner, S
Citation: Ce. Hioe et al., Inhibition of human immunodeficiency virus type 1 gp120 presentation to CD4 T cells by antibodies specific for the CD4 binding domain of gp120, J VIROLOGY, 75(22), 2001, pp. 10950-10957
Direct ex vivo measurement of CD8(+) T-lymphocyte responses to human parvovirus B19
Authors: Tolfvenstam, T Oxenius, A Price, DA Shacklett, BL Spiegel, HML Hedman, K Norbeck, O Levi, M Olsen, K Kantzanou, M Nixon, DF Broliden, K Klenerman, P
Citation: T. Tolfvenstam et al., Direct ex vivo measurement of CD8(+) T-lymphocyte responses to human parvovirus B19, J VIROLOGY, 75(1), 2001, pp. 540-543
Functional heterogeneity of cytokines and cytolytic effector molecules in human CD8(+) T lymphocytes
Authors: Sandberg, JK Fast, NM Nixon, DF
Citation: Jk. Sandberg et al., Functional heterogeneity of cytokines and cytolytic effector molecules in human CD8(+) T lymphocytes, J IMMUNOL, 167(1), 2001, pp. 181-187
A novel technique for the fluorometric assessment of T lymphocyte antigen specific lysis (vol 249, pg 99, 2001)
Authors: Sheehy, ME McDermott, AB Furlan, SN Klenerman, P Nixon, DF
Citation: Me. Sheehy et al., A novel technique for the fluorometric assessment of T lymphocyte antigen specific lysis (vol 249, pg 99, 2001), J IMMUNOL M, 252(1-2), 2001, pp. 219-220
A novel technique for the fluorometric assessment of T lymphocyte antigen specific lysis
Authors: Sheehy, ME McDermott, AB Furlan, SN Klenerman, P Nixon, DF
Citation: Me. Sheehy et al., A novel technique for the fluorometric assessment of T lymphocyte antigen specific lysis, J IMMUNOL M, 249(1-2), 2001, pp. 99-110
Why do cytotoxic T lymphocytes fail to eliminate hepatitis C virus? Lessons from studies using major histocompatibility complex class I peptide tetramers
Authors: Lechner, F Sullivan, J Spiegel, H Nixon, DF Ferrari, B Davis, A Borkowsky, B Pollack, H Barnes, E Dusheiko, G Klenerman, P
Citation: F. Lechner et al., Why do cytotoxic T lymphocytes fail to eliminate hepatitis C virus? Lessons from studies using major histocompatibility complex class I peptide tetramers, PHI T ROY B, 355(1400), 2000, pp. 1085-1092
Evaluation of a lipopeptide immunogen as a therapeutic in HIV type 1-seropositive individuals
Authors: Seth, A Yasutomi, Y Jacoby, H Callery, JC Kaminsky, SM Koff, WC Nixon, DF Letvin, NL
Citation: A. Seth et al., Evaluation of a lipopeptide immunogen as a therapeutic in HIV type 1-seropositive individuals, AIDS RES H, 16(4), 2000, pp. 337-343
Isolation of cytomegalovirus-specific cytotoxic T-lymphocytes from gut-associated lymphoid tissue (GALT) of HIV type 1-infected subjects
Authors: Shacklett, BL Beadle, TJ Pacheco, PA Grendell, JH Haslett, PAJ King, AS Ogg, GS Basuk, PM Nixon, DF
Citation: Bl. Shacklett et al., Isolation of cytomegalovirus-specific cytotoxic T-lymphocytes from gut-associated lymphoid tissue (GALT) of HIV type 1-infected subjects, AIDS RES H, 16(12), 2000, pp. 1157-1162
Identification of subdominant cytotoxic T lymphocyte epitopes encoded by autologous HIV type 1 sequences, using dendritic cell stimulation and computer-driven algorithm
Authors: Jin, X Roberts, CGP Nixon, DF Safrit, JT Zhang, LQ Huang, YX Bhardwaj, N Jesdale, B DeGroot, AS Koup, RA
Citation: X. Jin et al., Identification of subdominant cytotoxic T lymphocyte epitopes encoded by autologous HIV type 1 sequences, using dendritic cell stimulation and computer-driven algorithm, AIDS RES H, 16(1), 2000, pp. 67-76
Rapid quantification of SIV-specific CD8 T cell responses with recombinantvaccinia virus ELISPOT or cytokine flow cytometry
Authors: Moretto, WJ Drohan, LA Nixon, DF
Citation: Wj. Moretto et al., Rapid quantification of SIV-specific CD8 T cell responses with recombinantvaccinia virus ELISPOT or cytokine flow cytometry, AIDS, 14(16), 2000, pp. 2625-2627
Risks and benefits of structured antiretroviral drug therapy interruptionsin HIV-1 infection
Authors: Bonhoeffer, S Rembiszewski, M Ortiz, GM Nixon, DF
Citation: S. Bonhoeffer et al., Risks and benefits of structured antiretroviral drug therapy interruptionsin HIV-1 infection, AIDS, 14(15), 2000, pp. 2313-2322
Quantification of HIV-1-specific T-cell responses at the mucosal cervicovaginal surface
Authors: Shacklett, BL Cu-Uvin, S Beadle, TJ Pace, CA Fast, NM Donahue, SM Caliendo, AM Flanigan, TP Carpenter, CCJ Nixon, DF
Citation: Bl. Shacklett et al., Quantification of HIV-1-specific T-cell responses at the mucosal cervicovaginal surface, AIDS, 14(13), 2000, pp. 1911-1915
Direct measurement of CD8+T cell responses in macaques infected with simian immunodeficiency virus
Authors: Donahoe, SM Moretto, WJ Samuel, RV Metzner, KJ Marx, PA Hanke, T Connor, RI Nixon, DF
Citation: Sm. Donahoe et al., Direct measurement of CD8+T cell responses in macaques infected with simian immunodeficiency virus, VIROLOGY, 272(2), 2000, pp. 347-356
Characterization of HIV-1-specific cytotoxic T lymphocytes expressing the mucosal lymphocyte integrin CD103 in rectal and duodenal lymphoid tissue ofHIV-1-infected subjects
Authors: Shacklett, BL Beadle, TJ Pacheco, PA Grendell, JH Haslett, PAJ King, AS Ogg, GS Basuk, PM Nixon, DF
Citation: Bl. Shacklett et al., Characterization of HIV-1-specific cytotoxic T lymphocytes expressing the mucosal lymphocyte integrin CD103 in rectal and duodenal lymphoid tissue ofHIV-1-infected subjects, VIROLOGY, 270(2), 2000, pp. 317-327
Simian immunodeficiency virus-specific cytotoxic T lymphocytes and protection against challenge in rhesus macaques immunized with a live attenuated simian immunodeficiency virus vaccine
Authors: Nixon, DF Donahoe, SM Kakimoto, WM Samuel, RV Metzner, KJ Gettie, A Hanke, T Marx, PA Connor, RI
Citation: Df. Nixon et al., Simian immunodeficiency virus-specific cytotoxic T lymphocytes and protection against challenge in rhesus macaques immunized with a live attenuated simian immunodeficiency virus vaccine, VIROLOGY, 266(1), 2000, pp. 203-210
Human immunodeficiency virus type 1-and cytomegalovirus-specific cytotoxicT lymphocytes can persist at high frequency for prolonged periods in the absence of circulating peripheral CD4(+) T cells
Authors: Spiegel, HML Ogg, GS DeFalcon, E Sheehy, ME Monard, S Haslett, PAJ Gillespie, G Donahoe, SM Pollack, H Borkowsky, W McMichael, AJ Nixon, DF
Citation: Hml. Spiegel et al., Human immunodeficiency virus type 1-and cytomegalovirus-specific cytotoxicT lymphocytes can persist at high frequency for prolonged periods in the absence of circulating peripheral CD4(+) T cells, J VIROLOGY, 74(2), 2000, pp. 1018-1022
Enhancement of human immunodeficiency virus type 1-specific CD4 and CD8 T cell responses in chronically infected persons after temporary treatment interruption
Authors: Papasavvas, E Ortiz, GM Gross, R Sun, JW Moore, EC Heymann, JJ Moonis, M Sandberg, JK Drohan, LA Gallagher, B Shull, J Nixon, DF Kostman, JR Montaner, LJ
Citation: E. Papasavvas et al., Enhancement of human immunodeficiency virus type 1-specific CD4 and CD8 T cell responses in chronically infected persons after temporary treatment interruption, J INFEC DIS, 182(3), 2000, pp. 766-775
The impact of early initiation of highly active antiretroviral therapy on the human immunodeficiency virus type 1-specific CD8 T cell response in children
Authors: Spiegel, HML Chandwani, R Sheehy, ME Dobroszycki, J Fennelly, G Wiznia, A Radding, J Rigaud, M Pollack, H Borkowsky, W Rosenberg, M Nixon, DF
Citation: Hml. Spiegel et al., The impact of early initiation of highly active antiretroviral therapy on the human immunodeficiency virus type 1-specific CD8 T cell response in children, J INFEC DIS, 182(1), 2000, pp. 88-95
The relationship between T cell proliferative responses and plasma viremiaduring treatment of human immunodeficiency virus type 1 infection with combination antiretroviral therapy
Authors: Binley, JM Schiller, DS Ortiz, GM Hurley, A Nixon, DF Markowitz, MM Moore, JP
Citation: Jm. Binley et al., The relationship between T cell proliferative responses and plasma viremiaduring treatment of human immunodeficiency virus type 1 infection with combination antiretroviral therapy, J INFEC DIS, 181(4), 2000, pp. 1249-1263
Strong human immunodeficiency virus (HIV)-specific CD4(+) T cell responsesin a cohort of chronically infected patients are associated with interruptions in anti-HIV chemotherapy
Authors: Haslett, PAJ Nixon, DF Shen, Z Larsson, M Cox, WI Manandhar, R Donahoe, SM Kaplan, G
Citation: Paj. Haslett et al., Strong human immunodeficiency virus (HIV)-specific CD4(+) T cell responsesin a cohort of chronically infected patients are associated with interruptions in anti-HIV chemotherapy, J INFEC DIS, 181(4), 2000, pp. 1264-1272
Risultati: 1-25 | 26-35